VERU INC. Share-based Payment Arrangement, Expense, Tax Benefit
VERU INC. (VERU) reported Share-based Payment Arrangement, Expense, Tax Benefit of $2.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2025-12-17
- VERU INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $2.00M, a 35.48% decline from fiscal 2024.
- VERU INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $3.10M, a 22.50% decline from fiscal 2023.
- VERU INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $4.00M, a 60.00% increase from fiscal 2022.
- VERU INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $2.50M, a 127.27% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|
| 2025-09-30 | $2.00M 10-K · filed 2025-12-17 |
| 2024-09-30 | $3.10M 10-K · filed 2025-12-17 |
| 2023-09-30 | $4.00M 10-K · filed 2024-12-16 |
| 2022-09-30 | $2.50M 10-K/A · filed 2024-04-01 |
| 2021-09-30 | $1.10M 10-K · filed 2022-12-05 |
| 2020-09-30 | $599.00K 10-K · filed 2021-12-02 |
| 2019-09-30 | $431.00K 10-K · filed 2020-12-10 |
| 2018-09-30 | $426.00K 10-K · filed 2019-12-12 |
| 2017-09-30 | $304.00K 10-K · filed 2018-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |